Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

詳細記述

書誌詳細

主要な著者:	Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2022-01-01
シリーズ:	Pilot and Feasibility Studies
主題:	Phenobarbital; Alcohol withdrawal Delirium tremens Treatment
オンライン･アクセス:	https://doi.org/10.1186/s40814-021-00963-4
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!